期刊文献+

Barrett食管内镜及病理分析 被引量:1

Analysis of Endoscopic and pathological characteristics of Barrett' Sesophagus
原文传递
导出
摘要 目的探讨Barrett食管的内镜及病理特点。方法对新疆维吾尔自治区人民医院2013年1月至2015年5月365例经胃镜检查、病理诊断的Barrett食管患者资料进行回顾性分析。结果 Barrett食管患者以40~60岁较多。临床症状与胃食管反流病有不同程度重叠,反酸278例(76.1%),胃灼热171例(46.8%),上腹痛167例(45.7%),胸骨后疼痛77例(21%),无症状49例(13.4%)。胃镜下可见岛型234例(64.1%),舌型74例(20.2%),全周型57例(15.6%)。病理分型:肠化腺型上皮98例(26.8%),胃底腺型上皮134例(36.7%),贲门腺型133例(36.4%)。结论 Barrett食管多见于中年人,临床表现主要为胃食管反流的症状,电子胃镜下以岛型最多见,病理类型以胃底腺型及贲门腺型为主。 Objective To investigate the endoscopic and pathological characteristics of Barrett esophagus( BE). Methods Clinical data of 365 patients who were diagnosed as having BE with endoscopy and pathology in People's Hospital of Xinjiang Uygur Autonomous Region,from January 2013 to May 2015,were retrospectively analyzed. Results BE was most commonly seen in patients of 40 to 60 years old. The clinical manifestations overlapped in different patients,Including regurgitation in 278( 76. 1%),heartburn in 171( 46. 8%),retrostemal pain in 77( 21%),upper abdominal pain in 167( 45. 7%),asymptomatic in 49( 13. 4%). Under electronic gastroscopy,appearance of Mashima type was investigated in 234 patients( 64. 1%),tongue type change was found in 74 patients( 20. 2%),and the remaining were whole-week type change( 15. 6%). The results of pathological changes showed that the normal squamous epithelium was replaced by intestinal epithelium( 26. 8%),gastric epithelium( 36. 7%) and borderline epithelium( 36. 4%)separately. Conclusion Barrett' s esophagus is mainly seen in middle age population. Majority of symptoms for these patients are expressed as GERD. Mozhima type' s appearance is the main finding in gastroscopy,gastric epithelium and borderline epithelium main change in pathology.
出处 《中华胃食管反流病电子杂志》 2015年第3期152-154,共3页 Chinese Journal Of Gastroesophageal Reflux Disease(Electronic Edition)
关键词 BARRETT食管 电子胃镜检查 病理 Barrett esophagus Endoscopy Pathology
  • 相关文献

参考文献11

  • 1Desai TK, Krishnan K, SamalaN, et al. Howden CW ( 2012 ) The incidence of oesophageal adenoearcinoma in non-dysplasticBarrett' soesophagns:a meta-analysis[ J]. Gut,2012,61 (7) :970-976.
  • 2Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett' s esophagus[J]. Gut,2014,63( 1 ) :7-42.
  • 3Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States [ J ]. Cancer, 1998,83 ( 10 ) :2049-2053.
  • 4Amano Y, Kushiyama Y, Yuki T, et al. Prevalence ofand risk factots for Barrett's esophagus with intestinal predominant muein phenotype [ J ]. Scand J Gastroentero1,2006,41 ( 8 ) :873-879.
  • 5Labenz J, Koop H, TannapfelA, et al. The epidemiology, diagnosis, and treatment of Barrett' s carcinoma [ J ]. DtschArztebllnt, 2015, 112 ( 13 ) :224-233.
  • 6张秋瓒.Barrett食管发病机制研究进展[J].医学理论与实践,2009,22(4):405-407. 被引量:5
  • 7曾荣耀,刘静.Barrett食管的危险因素及治疗进展[J].中华消化外科杂志,2013,12(10):807-810. 被引量:12
  • 8中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10. 被引量:3337
  • 9Bhat S, Coleman HG,Yousef F, et al. Risk of malignant progression in Barrett'S esophagus patients:results from a large population based study [ J ]. J Natl Cancer Inst,2011,103 ( 13 ) : 1049-1057.
  • 10Chandrasoma P, Wijetunge S, DeMeester S, et al. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenoeareinoma[ J]. Am J SurgPatho1,2012,36( 1 ) : 1-7.

二级参考文献71

  • 1于中麟.Barrett食管内镜诊断进展[J].中华消化内镜杂志,2004,21(6):429-431. 被引量:25
  • 2张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 3房殿春,赵晶京.Barrett食管诊治共识(草案)[J].中华内科杂志,2006,45(4):349-350. 被引量:31
  • 4台卫平,张玫,罗和生.胆汁返流与Barrett食管及食管肿瘤[J].世界华人消化杂志,2006,14(9):884-887. 被引量:3
  • 5Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression[J].Gastroenterology, 1999,117 : 327-335.
  • 6Umansky M, Yasui W, Hallak A, et al. Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus[J]. Oncogene, 2001,20(55) : 7987-7991.
  • 7Souza RF, Shewmake K, Terada IS, et al. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus[J].Gastroenterology, 2002, 122(2) :299-307.
  • 8Goldstein SR, Yang GY, Curitis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a caxcinogen[J]. Carcinogenesis, 1997, 18 (11): 2265-2270.
  • 9Sital RR, Kusters JG, De Rooij FW, et al. Bile acids and Barrett's oesophagus: a sine qua non or coincidence[J].Scand J Gastroenterol Suppl, 2006 May, 243:11-17.
  • 10Hu Y,Williams VA,Gellersen O,et al. The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells[J]. J Gastrointest Surg, 2007, 11(7):827-834.

共引文献3358

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部